understanding the resorce data in second-line hcc
Published 7 years ago • 79 plays • Length 5:10Download video MP4
Download video MP3
Similar videos
-
2:01
dr franses on the need for prospective data in second-line hcc and beyond
-
5:53
underlying cirrhosis in the second-line setting of hcc
-
6:02
hcc: considerations in first-line use of sorafenib
-
4:32
overview and diagnosis of hcc
-
7:29
understanding how best to sequence in advanced hcc
-
6:39
emerging second-line therapies in hcc
-
6:51
hcc: use of lenvatinib and sorafenib
-
23:40
liver protocol :: sononerds:: doodle tutor
-
1:37:24
evidence-based treatment selection and sequencing in advanced hcc
-
45:53
hepatocellular carcinoma
-
2:04
dr. bruix on regorafenib in second-line hcc
-
4:11
second-line treatment for hepatocellular carcinoma
-
6:03
two options for checkpoint inhibition in hcc
-
4:29
second-line hcc: an historical perspective
-
1:15
dr. huey on the importance of patient selection in hcc
-
1:04
dr franses on considerations for second-line treatment of hcc
-
1:57
dr. kaseb on the progression of hcc research
-
5:40
sorafenib initiation after tace in hcc
-
4:24
optimal use of second-line tkis in hepatocellular carcinoma
-
3:00
ongoing clinical trials in second-line hcc
-
8:10
dosing strategies with sorafenib in hcc
-
11:18
debate: is there a standard second line therapy for hcc? - regorafenib is a winner